CEPHALOSPORINS
CEPHALOSPORINS- INTRODUCTION
- Cephalosporin discovery credited to Brotzu in 1945 in sewer water off coast of Sardinia
- Several compounds isolated from mold Acremonium chrysogenum as basic nucleus for future drugs
- First introduced into clinical use in 1964 (cephalosporin)
DEFINITION
- Cephalosporins are beta-lactam antimicrobials with bactericidal activity used to manage a wide range of infections from gram-positive bacteria.
- The Cephalosporins are structurally related to the penicillin’s chemical groups but have a varying pharmacologic properties and antimicrobial activities.
CLASSIFICATION OF CEPHALOSPORINS
First generation cephalosporins: These are group of cephalosporin which act against staphylococcal infection.
Example:
- Cephazolin sodium Dosage 500mg to 1gm, route IM or IV.
- Cephadrine: Dosage 125 to 250 mg, route IM or IV.
- Cephalexin: dosage 125, 250, 500 mg per oral capsules.
Second generation cephalosporins: These are antibiotics which act against staphylococcus and some of the gram negative micro organism.
Example:
- Cefuroxime: Tab 250 mg to 1.5 gm, syrup 25 mg per ml per oral route, Inj. 250 to 1 gm IM or IV.
- Cefemandole: Inj.1 to 2 gm IV
Third generation cephalosporins: These are antibiotics which are effective against gram negative micro organisms and has no effect on staphylococcal infection.
Example:
- Cefotaxime: Inj.1to 2gm IV or IM.
- Cefatizidime: Inj.250, 500, 1000mg IV or IM.
- Ceftriaxone: Inj. 125 to 1 gm IM or IV.
Fourth generation cephalosporins: These are Cephalosporins with bactericidal action. They exert greater anti bacterial effects than other Cephalosporins.
Example:
- Cefepime: Inj. 200 to 400 mg IV or IM
- Cefiprome: Inj. 500mg IV or IM
Fifth generation cephalosporins: These are advanced generation cephalosporin active against methicillin- resistant Staphylococcus aureus (MRSA) and Gram-positive bacteria. It retains the activity of later-generation cephalosporins having broad spectrum activity against gram negative bacteria.
Example:
- Ceftaroline fosamil (teflaro) 600mg IV
- Zerbaxa (ceftolozane and tazobactam) 1.5 gm IV
MECHANISM OF ACTION OF CEPHALOSPORINS
Cephalosporins act by penetrating in to the bacterial cell wall
↓
They bind with the proteins in the cell wall & block them
↓
causes Instability of the bacterial cell wall
↓
Inhibits the multiplication of cells and cell wall synthesis
↓
Bacteria loses its potency
↓
Death of micro organism.
DRUG INTERACTION OF CEPHALOSPORINS
- The drug reacts when taken with alcohol
- Exhibits toxic effects when administered with aminoglycosides
- Decreases the effect of drugs like erythromycin and chloramphenicol.
PHARMACOKINETICS OF CEPHALOSPORINS
- Oral absorption of drug is poor.
- Most Cephalosporins can only be administered parenterally.
- When injected Intravenously the drug remains in circulation for 8 to 12 hrs.
- Cephalosporins are eliminated mostly by the kidneys, some with a substantial contribution from active tubular secretion.
- Only a few cephalosporins have a high biliary elimination.
INDICATIONS OF CEPHALOSPORINS
- Tonsillitis
- Respiratory infections
- Otitis Media
- Septicemia
- Urinary tract Infection
- Bone and joint infection
- GI infections
- Meningitis
- Skin and soft tissue infections
- Strep throat
- Sinus infections
- Gonorrhea
- Lyme disease
- Methicillin Resistant staphylococcus aureus
CONTRAINDICATIONS OF CEPHALOSPORINS
- Pregnancy
- Lactation
- Renal disease
- Hypersensitivity/ allergic to penicillin
- Toxic Effects
- Renal toxicity
- Ototoxicity
ADVERSE & SIDE-EFFECTS OF CEPHALOSPORINS
- Joint Pain, weakness & fatigue
- Dyspnea & swelling in the tongue & throat
- fever & chills
- Abdominal pain, Anorexia, nausea, vomiting & diarrhea
- Thrombocytopenia, eosinophilia, anemia & leucopenia
- urticaria, rash & paresthesia
- Hypersensitivity Reaction
NURSING RESPONSIBILITY IN ADMINISTERING THE DRUG
- Assess sensitivity to Cephalosporins by administering test dose
- Monitor vital signs
- Maintain intake output chart
- Monitor the skin for rash and allergic reactions
- Monitor for any changes in the tongue & throat and withdraw the drug if there is swelling
- Monitor the breathing pattern of the client & Administer Oxygen therapy, if needed
- Monitor Blood studies CBC, RFT, LFT before administration of the drug to identify toxicity
- Perform ear examinations and inform the client about the adverse effect and notify the physician if there is any signs of toxicity like hard of hearing, tinnitus, vertigo etc.
- Monitor for any signs of bleeding after drug administration
- Dilute the drug in 20 to 100 ml solution before administration to prevent thrombophlebitis
- Advise the patient to avoid alcohol
- Monitor for GI disturbances
- Administer the drug in caution for patients with seizure disorder and for clients on Anti-coagulants
- Evaluate therapeutic response treatment of infection.